Eye Health Supplements Market Trends: New Formulations and Product Launches

The global eye health supplements market is experiencing substantial growth, driven by a surge in the prevalence of eye-related disorders and an increased awareness of the importance of eye health. Individuals are increasingly turning to dietary supplements to maintain their overall well-being and enhance their immune systems, with a specific focus on eye health. This growing trend has been further accelerated by the rise in eye conditions such as age-related macular degeneration (AMD), dry eye syndrome, eye inflammation, and cataracts. According to the International Agency for the Prevention of Blindness (IAPB), AMD is now one of the leading causes of blindness, and it is projected that by the end of 2040, over 285 million individuals will develop AMD, imposing a significant health and financial burden, particularly on middle and low-income populations.

Furthermore, uncontrolled diabetes is a significant contributor to eye disorders, such as diabetic retinopathy. This, coupled with the increasing aging population, is expected to boost the consumption of eye health supplements. The United Nations estimates that by the end of 2050, the global population aged 65 and above will reach 1.5 billion. Additionally, the World Health Organization (WHO) reports that approximately 2 billion people worldwide developed vision impairment in 2021, further driving the demand for eye health supplements.

Rising Demand for Lutein- and Zeaxanthin-Based Supplements

Among the various eye health supplements, those containing Lutein and Zeaxanthin have witnessed significant demand growth. These ingredients are highly sought after due to their effectiveness in treating various eye disorders, including macular degeneration, uveitis, cataracts, and diabetic retinopathy. Ophthalmologists are increasingly recommending Lutein and Zeaxanthin-based supplements as the prevalence of eye disorders continues to rise. According to the National Institutes of Health Office of Dietary Supplements, the average intake of Lutein and Zeaxanthin is 1-3 mg for maintaining eye health, but daily intake recommendations range from 6-20 mg. This shift is expected to result in the inclusion of these supplements in regular diets, contributing to the growth of the eye health supplements market.

North America Emerges as Dominant Market

North America is at the forefront of the global eye health supplements market, driven by the increasing prevalence of diabetes, a growing geriatric population, and rising cases of AMD in the region. Age-related Macular Degeneration (AMD) is a significant concern, predominantly affecting individuals aged 60 and above in the United States. It is estimated that around 11 million Americans develop some form of AMD, a number projected to exceed 21 million by 2050. The risk of AMD increases by 2% among individuals aged 50-59 and by about 30% in those aged 75 and above. These statistics underscore the strong demand for eye health supplements in North America.

Moreover, the region boasts a robust infrastructure and economic growth, attracting major players in the eye health supplements industry. These companies are introducing new products to cater to the increasing demand from individuals with eye disorders. For example, TJ Nutrition launched Parasym Plus Eyes in 2021, a patented compound that reduces eye inflammation while simultaneously improving ocular systemic health. Such innovations are expected to further drive the growth of the eye health supplements market in North America.

Competitive Landscape

Key players in the eye health supplements market are actively engaged in the development of new formulations and product launches to meet growing demand. Notably, in 2022, Entod Pharmaceuticals launched Macusaff, a saffron-based eye health supplement. Similarly, Wellbeing Nutrition introduced Melts Eye Care in the same year, a natural eye vitamin utilizing advanced nanotechnology for enhanced effectiveness compared to conventional eye care tablets and capsules. Prominent companies in the market include Bausch & Lomb Incorporated, Amway International, Vitabiotics Ltd., Vestige Pvt. Ltd., ZeaVision LLC, Akorn Consumer Health, Pfizer Inc., EyeScience, Kemin Industries Inc., and Nutrachamps.

The global eye health supplements market is poised for continued growth as eye-related disorders continue to impact populations worldwide. Increasing awareness of the importance of eye health and the availability of effective supplements are driving this markets expansion.

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/eye-health-supplements-market

Our Blogs:

https://hackmd.io/@E4v1isUnROG4-prBVaQQGw/r1HtJRpR2

https://demcra.com/r/business/1132045_Global_Exhaust_Manifold_Market_Soars_Towards_a_10_Billion_Valuation_by_2030

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of

services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

Contact

Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746

Web: https://www.fairfieldmarketresearch.com/

Email: sales@fairfieldmarketresearch.com

LinkedIn | Twitter

This press release first seen on Brilad

comtex tracking

COMTEX_442085762/2840/2023-10-18T16:49:25

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Boston New Times  journalist was involved in the writing and production of this article.

Written by